CSI Market
Sign In | Register

Eupraxia Pharmaceuticals Inc (EPRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EPRX Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Eupraxia Pharmaceuticals Inc adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash & cash equivalent80.56
Cash & Short-term Investments80.00
Accounts receivable0.72
Nontrade Receivables, Current0.67
Other Current Assets0.00
Prepaid Expense, Current AS3.86
Total Current Assets85.10
Equipment/Property/Plant Net0.64
Tax Assets, Noncurrent4.70
Prepaid Expense, Noncurrent, Total PR0.06
Other Assets, Noncurrent0.15
Total Assets86.15
Liabilities
Accounts Payable and Accrued Liabilities, Current LI5.55
Accrued Liabilities, Current0.00
Taxes Payable0.00
Total Current Liabilities5.63
Total Long-term Debt0.00
Other liabilities, Noncurrent0.15
Total Liabilities5.70
Stockholders' Equity
Common Stock Value195.41
Additional Paid In Capital Common Stock28.52
Retained Earnings / Accumulated Deficit-169.58
Accumulated Other Comprehensive Income-2.04
Other Equity-2.04
Common Stockholder's Equity82.04
Non-controlling interests & other-1.60
Total Stockholder's Equity82.04
Liabilities & Stockholder's Equity86.15
4 historic quarters locked

Sign in to unlock the full Eupraxia Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Eupraxia Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 40-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 40-F (Period: 20251231)
  • Filed with the SEC: March 12, 2026
  • Source: d78249d40f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-104765

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.